1. 122MO Cemiplimab (cemi) + platinum doublet chemotherapy (chemo) + ipilimumab (ipi) for first-line treatment of advanced non-small cell lung cancer (NSCLC): EMPOWER-Lung 3 part I. (December 2022) Authors: Baramidze, A.; Gogishvili, M.; Melkadze, T.; Giorgadze, D.; Penkov, K.D.; Makharadze, T.; Kalinka, E.; Nechaeva, M.; Laktionov, K.; Gessner, C.; Moreno Jaime, B.; Passalacqua, R.; Garassino, M.C.; Li, S.; Pouliot, J-F.; McGuire, K.; Quek, R.G.; Kaul, M.; Gullo, G.; Rietschel, P. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 168P Liver metastases (mets) and treatment effect of cemiplimab-based therapy: An analysis from three phase III trials (EMPOWER-Lung 1, EMPOWER-Lung 3 part 2, and EMPOWER-Cervical 1). (December 2022) Authors: Baramidze, A.; Gessner, C.; Gogishvili, M.; Sezer, A.; Makharadze, T.; Kilickap, S.; Gumus, M.; Tewari, K.S.; Monk, B.J.; de Melo, A.C.; Oaknin, A.; Li, S.; Gao, B.; Mathias, M.D.; Gullo, G.; Salvati, M.E.; Seebach, F.; Lowy, I.; Fury, M.; Rietschel, P. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2862 The influence of time to objective response on lenvatinib clinical outcomes in the phase 3 SELECT trial. (September 2015) Authors: Newbold, K.; Sherman, S.; Wirth, L.J.; Habra, M.A.; Rietschel, P.; Song, J.; Schlumberger, M.; Gianoukakis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient-reported outcomes (PROs) of cemiplimab (CEMI) versus platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%: A focus on EMPOWER-Lung 1 (NCT03088540) age subgroups. (October 2022) Authors: Gogishvili, M.; Kilickap, S.; Sezer, A.; Gümüş, M.; Bondarenko, I.; Özgüroğlu, M.; He, X.; Gullo, G.; Rietschel, P.; Quek, R.G.W. Journal: Journal of geriatric oncology Issue: Volume 13(2022)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗